ContraFect Corporation is a biotechnology business based in the US. ContraFect Corporation shares (CFRX) are listed on the NASDAQ and all prices are listed in US Dollars. ContraFect Corporation employs 33 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in ContraFect Corporation
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CFRX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
ContraFect Corporation stock price (NASDAQ: CFRX)Use our graph to track the performance of CFRX stocks over time.
ContraFect Corporation shares at a glance
|Latest market close||$4.04|
|52-week range||$3.44 - $7.30|
|50-day moving average||$4.15|
|200-day moving average||$4.67|
|Wall St. target price||$14.33|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.44|
Buy ContraFect Corporation shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy ContraFect Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ContraFect Corporation price performance over time
|1 week (2021-07-12)||-3.12%|
|1 month (2021-06-23)||2.80%|
|3 months (2021-04-19)||N/A|
|6 months (2021-01-19)||N/A|
|1 year (2020-07-19)||N/A|
|2 years (2019-07-19)||N/A|
|3 years (2018-07-19)||N/A|
|5 years (2016-07-19)||N/A|
ContraFect Corporation financials
|Gross profit TTM||$-1,606,434|
|Return on assets TTM||-37.55%|
|Return on equity TTM||-73.1%|
|Market capitalisation||$160.1 million|
TTM: trailing 12 months
Shorting ContraFect Corporation shares
There are currently 3.4 million ContraFect Corporation shares held short by investors – that's known as ContraFect Corporation's "short interest". This figure is 27.2% down from 4.7 million last month.
There are a few different ways that this level of interest in shorting ContraFect Corporation shares can be evaluated.
ContraFect Corporation's "short interest ratio" (SIR)
ContraFect Corporation's "short interest ratio" (SIR) is the quantity of ContraFect Corporation shares currently shorted divided by the average quantity of ContraFect Corporation shares traded daily (recently around 491560.14388489). ContraFect Corporation's SIR currently stands at 6.95. In other words for every 100,000 ContraFect Corporation shares traded daily on the market, roughly 6950 shares are currently held short.
However ContraFect Corporation's short interest can also be evaluated against the total number of ContraFect Corporation shares, or, against the total number of tradable ContraFect Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ContraFect Corporation's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 ContraFect Corporation shares in existence, roughly 90 shares are currently held short) or 0.1085% of the tradable shares (for every 100,000 tradable ContraFect Corporation shares, roughly 109 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against ContraFect Corporation.
Find out more about how you can short ContraFect Corporation stock.
ContraFect Corporation share dividends
We're not expecting ContraFect Corporation to pay a dividend over the next 12 months.
Have ContraFect Corporation's shares ever split?
ContraFect Corporation's shares were split on a 1:10 basis on 3 February 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ContraFect Corporation shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for ContraFect Corporation shares which in turn could have impacted ContraFect Corporation's share price.
ContraFect Corporation share price volatility
Over the last 12 months, ContraFect Corporation's shares have ranged in value from as little as $3.44 up to $7.3. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ContraFect Corporation's is 0.938. This would suggest that ContraFect Corporation's shares are less volatile than average (for this exchange).
ContraFect Corporation overview
ContraFect Corporation, a clinical-stage biotechnology company, focuses on the discovery and development of therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead product candidates consist of CF-301, an investigational novel lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia, including endocarditis caused by methicillin-resistant or methicillin-susceptible. The company also develops CF-296, an engineered lysin, used for treatment of the invasive infections caused by staph aureus including biofilm-related infections in prosthetic joints and indwelling devices and osteomyelitis; and CF-370, an investigational anti-bacterial therapeutic candidate, which in preclinical trials for the treatment of pseudomonas aeruginosa infections, including ventilator associated pneumonia, blood stream infections, complicated urinary tract infections, and surgery carry infections. The company has a collaboration research agreement with The Rockefeller University to identification of novel lysin therapeutic candidates targeting gram-negative pathogens. It also initiated an expanded access program to provide exebacase for the treatment of persistent bacteremia caused by methicillin-resistant Staphylococcus aureus in COVID-19 patients. The company was incorporated in 2008 and is headquartered in Yonkers, New York. .
Stocks similar to ContraFect Corporation
ContraFect Corporation in the news
ContraFect Announces Multiple Presentations of New Research Data From Its Pipeline of Direct Lytic Agents at the 31st ECCMID
ContraFect Announces Multiple Publications on CF-296 Demonstrating Potent In Vivo Antimicrobial Activity
ContraFect announces multiple presentations on new research data from DLAs
Frequently asked questionsWhat percentage of ContraFect Corporation is owned by insiders or institutions?
Currently 4.871% of ContraFect Corporation shares are held by insiders and 66.616% by institutions. How many people work for ContraFect Corporation?
Latest data suggests 33 work at ContraFect Corporation. When does the fiscal year end for ContraFect Corporation?
ContraFect Corporation's fiscal year ends in December. Where is ContraFect Corporation based?
ContraFect Corporation's address is: 28 Wells Avenue, Yonkers, NY, United States, 10701 What is ContraFect Corporation's ISIN number?
ContraFect Corporation's international securities identification number is: US2123263004 What is ContraFect Corporation's CUSIP number?
ContraFect Corporation's Committee on Uniform Securities Identification Procedures number is: 212326102
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert